NCT04173507 2024-09-03Combination Treatment (Talazoparib Plus Avelumab) for Stage IV or Recurrent Non-Squamous Non-Small Cell Lung Cancer With STK11 Gene Mutation (A LUNG-MAP Treatment Trial)SWOG Cancer Research NetworkPhase 2 Completed47 enrolled 17 charts